Results 201 to 210 of about 1,457,300 (387)

Immunology [PDF]

open access: yes, 2016
小林 栄治   +5 more
core   +3 more sources

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

open access: yesArthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry   +16 more
wiley   +1 more source

Correction: Distinct <i>Arnica montana</i> L. extracts modulate human T cell activation in different ways via differential inhibition of NFκB and NFAT pathways. [PDF]

open access: yesFront Immunol
Berschneider KM   +13 more
europepmc   +1 more source

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

open access: yesArthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla   +13 more
wiley   +1 more source

Immunology

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2003
doaj   +1 more source

Fifty Years of Natural Killer Cells: Milestones and Future Horizons. [PDF]

open access: yesScand J Immunol
Lundqvist A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy